The first adult CAR T-cell treatment for lymphoma or leukemia has been approved by the FDA.

Published Date: 20 Mar 2024

The US. s. The FDA has authorized Breyanzi, a medication made by Bristol Myers Squibb that combines lipase and maraleucel (liso-cel), as the first CD19-directed chimeric antigen receptor (CAR) T-cell therapy for adult patients experiencing relapses.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

2.

Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.

3.

Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap

4.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

5.

Potential new therapy for childhood brain cancer could heal treatment-resistant tumors


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot